All News

2055 articles, sorted by publication time.

Drug Development · global

Mixed Phase 3 Results for AriBio’s Oral Alzheimer’s Drug: 31% Slower Decline in Monotherapy Population, No Significant Benefit Overall

AR1001 met the prespecified efficacy threshold in 604 patients not taking certain existing therapies but did not demonstrate a benefit across all 1,535 participants. The results offer clues for oral treatment while putting the eligible patient population and strength of evidence at the center of the next regulatory discussions.

Clinical Research · global

Helping the Immune System Accept a Transplanted Liver: UCLA Trial Explores Stopping Anti-Rejection Drugs

A strategy adapted from kidney transplantation involves infusing blood-forming stem cells from the original donor into the recipient to try to establish immune tolerance. This liver transplant trial, which plans to enroll 12 people, must first answer whether patients can safely stop medication while preserving the transplanted organ.

Gene and Cell Therapy · global

Delivering DNA into the Cell Nucleus: Seawolf Raises $100 Million and Partners with Sanofi to Develop New Therapies

Seawolf aims to enable cells to keep producing therapeutic proteins while retaining the flexibility to administer additional doses. Its nonviral DNA delivery technology has attracted funding and a pharmaceutical partnership, but whether it can deliver both durability and safety in humans remains to be established in clinical trials.